Alias: "Mycobacterium xenopei" (sic) Schwabacher 1959, Mycobacterium xenopei, Mycobacterium xenopi Schwabacher 1959, Mycobacterium xenopii
Publications109 found, 100 shown here
- Performance assessment of new multiplex probe assay for identification of mycobacteriaE Tortoli
Centro Regionale di Riferimento per la Diagnostica delle Micobatteriosi, Laboratorio di Microbiologia e Virologia, Ospedale di Careggi, Piastra del servizi, Viale Morgagni 85, 50134 Florence, Italy
J Clin Microbiol 39:1079-84. 2001..hybridization and line-probe technology, of Mycobacterium tuberculosis complex, Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium gordonae, the species of the Mycobacterium avium complex (MAC), Mycobacterium scrofulaceum, ..
- [Lung changes caused by Mycobacterium xenopi infection in a patient with bone marrow transplantation: problems in differential diagnosis]F W Busch
Pneumologie 45:340-2. 1991..We here report a case of pulmonary infiltrates due to Mycobacterium xenopi in a patient after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete ..
- Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture systemClaudio Piersimoni
Department of Clinical Microbiology, United Hospitals, Via Conca 71, Ancona I 60020, Italy
J Clin Microbiol 47:804-6. 2009..Three hundred sixty-nine mycobacterial strains were recovered; of the 44 Mycobacterium xenopi isolates recovered by MGIT medium, only 13 were detected by the instrument (P<0.0001)...
- Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. novP Torkko
Laboratory of Environmental Microbiology, National Public Health Institute, Kuopio, Finland
Int J Syst Evol Microbiol 50:283-9. 2000Three scotochromogenic Mycobacterium xenopi-like organisms were isolated from stream waters in Finland. These strains grew at 36-50 degrees C but not at 30 degrees C. One of the three strains was fully compatible with the M...
- Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreakP Astagneau
C CLIN Paris Nord, Paris, France
Lancet 358:747-51. 2001b>Mycobacterium xenopi spinal infections were diagnosed in 1993 in patients who had undergone surgical microdiscectomy for disc hernia, by nucleotomy or microsurgery, in a private hospital...
- Creation of an artificial bifunctional intein by grafting a homing endonuclease into a mini-inteinMarilena Fitzsimons Hall
New England Biolabs, Inc, 32 Tozer Road, Beverly, MA 01915, USA
J Mol Biol 323:173-9. 2002..The gene for I-CreI, an intron-encoded homing endonuclease, was grafted into the monofunctional Mycobacterium xenopi GyrA intein at the putative site of the missing endonuclease...
- Mycobacterium xenopi and drinking water biofilmsM Dailloux
Laboratoire de Bactériologie CHU Brabois, 54511 Vandoeuvre les Nancy, France
Appl Environ Microbiol 69:6946-8. 2003The ability of Mycobacterium xenopi to colonize an experimental drinking water distribution system (a Propella reactor) was investigated. M. xenopi was present in the biofilm within an hour following its introduction...
- Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanerceptKyongwook Yim
Division of Infectious Diseases, Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA
Scand J Infect Dis 36:150-4. 2004A case of recurrent Mycobacterium xenopi infection presenting as Pott's disease in a patient receiving etanercept for severe rheumatoid arthritis is described...
- Clinical and therapeutic management of pulmonary Mycobacterium xenopi infection in HIV-positive patientsLidia Gazzola
Clin Infect Dis 38:1642-4; author reply 1644. 2004
- [Four cases of Mycobacterium xenopi pulmonary disease]Seigo Minami
Department of Respiratory Medicine, National Kinki Chuo Hospital for Chest Diseases, 1180, Nagasone cho, Sakai shi, Osaka 591 8025, Japan
Kekkaku 79:313-20. 2004b>Mycobacterium xenopi is very rare pathogen in Japan. We reported herein four cases of M. xenopi pulmonary disease. These patients were all male and their ages ranged from 53 to 72...
- [Molecular identification of mycobacteria and detection of antibiotic resistance]V Cattoir
Laboratoire de Bacteriologie virologie, Faculté de médecine de Rennes
Ann Biol Clin (Paris) 62:405-13. 2004..Nontuberculous mycobacteria (e.g. Mycobacterium avium-intracellulare, Mycobacterium kansasii, Mycobacterium xenopi or Mycobacterium ulcerans) can cause infections too, usually in particular clinical settings...
- [Metastatic endophthalmitis following lung transplantation]Eszter Csiszer
Országos Korányi Tbc és Pulmonológiai Intézet, Budapest
Orv Hetil 145:1719-21. 2004..The pathogens were Pseudomonas aeruginosa and Mycobacterium xenopi respectively...
- Species-specific identification of mycobacterial 16S rRNA PCR amplicons using smart probesKatharina Stöhr
Physikalisch Chemisches Institut, Universitat Heidelberg, Germany
Anal Chem 77:7195-203. 2005..tuberculosis complex) and Mycobacterium xenopi (member of the atypical mycobacteria) with a detection sensitivity of approximately 2 x 10(-8) M in ..
- Arthritis due to Mycobacterium xenopi: a retrospective study of 7 cases in FranceCarine Salliot
Department of Internal Medicine and Rheumatology, Diaconesses Croix Saint Simon Hospital, Paris, 75020, France
Clin Infect Dis 43:987-93. 2006b>Mycobacterium xenopi is a nontuberculous mycobacterium responsible for opportunistic and nosocomial infections, chiefly of the lung; few cases of bone and joint infection have been reported...
- Mycobacterium heckeshornense tenosynovitisSylvain Godreuil
Laboratoire de Bacteriologie, Hopital Arnaud de Villeneuve, Montpellier, France
Scand J Infect Dis 38:1098-101. 2006..M. heckeshornense may cause a wide spectrum of human infectious diseases and may be underestimated due to its phenotypic relatedness with Mycobacterium xenopi.
- Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patientsClaire Andrejak
Pneumology Department, University Hospital, Amiens, 80054 Amiens Cedex 1, France
J Infect 55:34-40. 2007..The global number of non-tuberculous mycobacteria (NTM) pulmonary infections is increasing. Treatment decisions and management are difficult and the prognosis of these infections has been rarely evaluated...
- [Pulmonary infections with Mycobacterium xenopi in patients without HIV infection]A Dixmier
Service de Pneumologie, CHU Saint Antoine, Paris, France
Rev Mal Respir 24:299-304. 2007To determine the incidence, clinical characteristics, microbiological features and outcome of Mycobacterium xenopi infections in patients attending a university hospital.
- A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratoryK J Williams
Department of Microbiology, Royal Free Hospital, London NW3 2QG, UK
J Med Microbiol 56:598-602. 2007..avium complex, Mycobacterium fortuitum group, Mycobacterium chelonae-Mycobacterium abscessus group, Mycobacterium xenopi and Mycobacterium gordonae...
- [Peculiar "chestnuts in burrs" formation in MGIT cultures of pulmonary Mycobacterium xenopi cases]Keiko Abe
National Hospital Organization, Minami Yokohama National Hospital, Yokohama 233 8503
Rinsho Byori 55:1080-3. 2007..bronchoalveolar lavage fluid (BALF) cultures for acid fast bacteria in MGIT liquid media grew colonies of Mycobacterium xenopi (M. xenopi) with a characteristic chestnut burr like appearance...
- Mycobacterium xenopi clinical relevance and determinants, the NetherlandsJakko van Ingen
Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Emerg Infect Dis 14:385-9. 2008In the Netherlands, isolation of Mycobacterium xenopi is infrequent, and its clinical relevance is often uncertain...
- Tracheal granuloma because of infection with a novel mycobacterial species in an old FIV-positive catD De Lorenzi
San Marco Private Veterinary Clinic, Via Sorio 114 c, 35141 Padua, Italy
J Small Anim Pract 50:143-6. 2009..analysis identified a novel mycobacterial species, likely a slow grower, with 95 per cent identity with Mycobacterium xenopi. To our knowledge, this is the first description of a tracheal mycobacterial granuloma in a cat, and the ..
- Complete genome sequence of Mycobacterium xenopi type strain RIVM700367Abdallah M Abdallah
Pathogen Genomics Laboratory, Computational Bioscience Research Center, King Abdullah University of Science and Technology, Thuwal Jeddah, Saudi Arabia
J Bacteriol 194:3282-3. 2012b>Mycobacterium xenopi is a slow-growing, thermophilic, water-related Mycobacterium species. Like other nontuberculous mycobacteria, M...
- Identification of non-tuberculous mycobacteria from clinical samplesPaola Molicotti
Department of Biomedical Sciences University of Sassari
New Microbiol 36:409-11. 2013..Mycobacterium avium, Mycobacterium gordonae and Mycobacterium xenopi were frequently found. Our results agreed with literature data both for the frequent isolation of M...
- Multilocus sequence typing of Mycobacterium xenopiDavid C Alexander
Public Health Ontario Laboratories, Public Health Ontario, Toronto, ON, Canada Saskatchewan Disease Control Laboratory, Saskatchewan Ministry of Health, Regina, SK, Canada
J Clin Microbiol 52:3973-7. 2014b>Mycobacterium xenopi is an opportunistic mycobacterial pathogen of increasing clinical importance. Surveillance of M. xenopi is hampered by the absence of tools for genotyping and molecular epidemiology...
- Comparative analysis of the effectiveness of C-terminal cleavage intein-based constructs in producing a recombinant analog of anophelin, an anticoagulant from Anopheles albimanusRoman S Esipov
Shemyakin Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16 10 Miklukho Maklaya St, Moscow, Russia, 117997
Appl Biochem Biotechnol 175:2468-88. 2015..We prepared two new such constructs with mini-inteins GyrA from Mycobacterium xenopi and RIR1 from Methanobacterium thermoautotrophicum...
- Engineering versatile protein expression systems mediated by inteins in Escherichia coliKeith W Y Kwong
Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
Appl Microbiol Biotechnol 100:255-62. 2016..In this study, we employed two structurally varied inteins, VMA and Mycobacterium xenopi GyraseA (GyrA), and further demonstrated that despite acting alone, both VMA and GyrA were able to mediate ..
- Update on pulmonary disease due to non-tuberculous mycobacteriaJason E Stout
Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Box 102359 DUMC, Durham, NC 27710, USA Electronic address
Int J Infect Dis 45:123-34. 2016..g., Mycobacterium malmoense, Mycobacterium xenopi) are regionally important...
- Establishment of intein-mediated protein ligation under denaturing conditions: C-terminal labeling of a single-chain antibody for biochip screeningJens R Sydor
Zyomyx, Inc, 26101 Research Road, Hayward, California 94545, USA
Bioconjug Chem 13:707-12. 2002..A GFPuv fusion protein with the Mycobacterium xenopi gyrA intein was expressed in inclusion bodies in Escherichia coli and initially used as a model protein to ..
- Development of a positive genetic selection system for inhibition of protein splicing using mycobacterial inteins in Escherichia coli DNA gyrase subunit AEric Adam
New England Biolabs, Beverly, MA 01915, USA
J Mol Microbiol Biotechnol 4:479-87. 2002..To demonstrate the efficacy of this system, mutations that blocked splicing of the Mycobacterium xenopi Gyrase A intein were isolated...
- In vitro sensitivity of Mycobacterium xenopi to five antibioticsJ N Dauendorffer
Laboratoire de Bacteriologie, CHU de Nancy, Allee du Morvan, 54511 Vandoeuvre les Nancy, France
Pathol Biol (Paris) 50:591-4. 2002We tested 20 strains of Mycobacterium xenopi (M...
- Psoas abscess due to Mycobacterium xenopi infectionDavid B Huang
Am J Med 114:247-9. 2003
- Mycobacterium xenopi pneumonia in the southeastern United StatesJihane A Faress
Veterans Affairs Medical Center, Mountain Home, TN 37684 4000, USA
South Med J 96:596-9. 2003b>Mycobacterium xenopi (M. xenopi) is a slow-growing, nontuberculous mycobacterium (NTM). This organism is found in fresh water and has been isolated in water samples collected from water systems in homes and hospitals...
- Novel mass spectrometry-based tool for genotypic identification of mycobacteriaMichael Lefmann
Institut für Mikrobiologie und Hygiene, Universitatsklinikum Charite, Humboldt Universitat zu Berlin, Germany
J Clin Microbiol 42:339-46. 2004..A 16S rDNA microheterogeneity of the Mycobacterium xenopi type strain (DSM 43995) was detected by MALDI-TOF MS and later confirmed by Sanger dideoxy sequencing...
- Development and evaluation of a Mycobacterium avium subspecies paratuberculosis (MAP) specific multiplex PCR assayT Tasara
Institute of Food Safety and Hygiene, Vetsuisse Faculty University of Zurich, Winterthurerstr 272, CH 8057 Zurich, Switzerland
Int J Food Microbiol 104:279-87. 2005..for the first time false positive IS900 PCR signals in Mycobacterium chelonae, Mycobacterium terrae and Mycobacterium xenopi strains associated with one of the established PCR systems widely used for MAP detection...
- Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water networkVincent Thomas
Center for Research on Intracellular Bacteria, Institute of Microbiology, CHUV Hospital, Bugnon 46, 1011 Lausanne, Switzerland
Appl Environ Microbiol 72:2428-38. 2006..5% of the samples, mycobacteria (Mycobacterium gordonae, Mycobacterium kansasii, and Mycobacterium xenopi) were recovered from 20.5% of the samples, and Gammaproteobacteria (Legionella) were recovered from 5...
- Asymptomatic Mycobacterium xenopi lung abscess in an immunocompetent male without pre-existing lung pathologyR Traboulsi
Division of Infectious Diseases, American University of Beirut Medical Center, Hamra, Lebanon
Scand J Infect Dis 38:541-5. 2006Like other non-tuberculous mycobacteria, Mycobacterium xenopi infects more commonly patients with altered immune defenses. In immunocompetent individuals, infection with M...
- Chronic disseminated Mycobacterium xenopi infection in a cat with idiopathic CD4+ T lymphocytopeniaC Meeks
Florida Veterinary Specialists, 3000 Busch Lake Boulevard, Tampa, FL, USA
J Vet Intern Med 22:1043-7. 2008
- [Mycobacterium xenopi: a rare mycobacterium?]J Moraza
Arch Bronconeumol 38:401-2. 2002
- Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?L Kerbiriou
Department of Respiratory Medicine, Royal Free Hospital, London, United Kingdom
Clin Infect Dis 37:1250-4. 2003..and were receiving highly active antiretroviral therapy (HAART) who had respiratory symptoms and from whom Mycobacterium xenopi was isolated. All patients also had coexisting pulmonary pathologic conditions...
- Chest computed tomography predicts microbiological burden and symptoms in pulmonary Mycobacterium xenopiTheodore K Marras
Departments of Medicine, University Health Network and Mount Sinai Hospital Toronto and University of Toronto, Toronto, Canada
Respirology 18:92-101. 2013..We sought to assess associations among CT features, symptoms and microbiological disease criteria in pulmonary Mycobacterium xenopi isolation.
- Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapyClaire Andrejak
Johns Hopkins University School of Medicine, Center for Tuberculosis Research, 1550 Orleans Street, Baltimore, MD 21231, USA
J Antimicrob Chemother 68:659-65. 2013b>Mycobacterium xenopi is a common agent of non-tuberculous mycobacterial lung diseases in Europe. However, an optimal treatment regimen for M. xenopi infection has not yet been established...
- [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]Mina Gochi
Department of Respiratory Medicine, The Jikei University Daisan Hospital, Japan
Kekkaku 87:733-6. 2012..The patient was diagnosed with Mycobacterium xenopi lung infection based on the presence of acid-fast bacilli in the sputum culture several times, which were ..
- Unusual coexistence of opportunistic lung infections in a human immunodeficiency virus positive patient suffering from persistent Pneumocystis jirovecii pneumonia: a case reportD Ponces Bento
Serviço de Infecciologia e Medicina Tropical, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal
Rev Port Pneumol 19:129-33. 2013..with multiple OI, including a persistent form of PcP, an invasive aspergillosis (IA), cytomegalovirus and Mycobacterium xenopi lung infection...
- Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculationJean Hugues Salmon
Service de Rhumatologie, CHU de Reims, 45, rue Cognac Jay, 51100 Reims, France
Joint Bone Spine 79:409-11. 2012A patient was diagnosed with discitis and sacroiliitis due to Mycobacterium xenopi. He had a history of percutaneous nucleotomy performed 15 years earlier (in 1992) at the Clinique du Sport, Paris, France, during an outbreak of nosocomial ..
- Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south LondonBethany S Davies
Department of Infection, Guys and St Thomas NHS Foundation Trust, London, UK
Scand J Infect Dis 44:815-9. 2012..UK data on slow-growing non-tuberculous mycobacterial (NTM) pulmonary infections are sparse and there is little consensus on optimal treatment regimens...
- Radiometric susceptibility testing of Mycobacterium xenopiE Tortoli
Microbiological and Virological Laboratory, Careggi Hospital, Florence, Italy
J Chemother 7:114-7. 1995b>Mycobacterium xenopi is an opportunistic pathogen, frequently isolated in various areas of Europe from pulmonary specimens, which may also cause infections in AIDS patients...
- The Mycobacterium xenopi GyrA protein splicing element: characterization of a minimal inteinA Telenti
Institut fur Medizinische Mikrobiologie, Universitat Bern, Switzerland
J Bacteriol 179:6378-82. 1997The 198-amino-acid in-frame insertion in the gyrA gene of Mycobacterium xenopi is the smallest known naturally occurring active protein splicing element (intein). Comparison with other mycobacterial gyrA inteins suggests that the M...
- Preliminary results of collapse therapy with plombage for pulmonary disease caused by multidrug-resistant mycobacteriaS Jouveshomme
Service de Pneumologie et de Reanimation Respiratoire, Hopital Pitie Salpetriere, Paris, France
Am J Respir Crit Care Med 157:1609-15. 1998..Four patients were infected with multidrug-resistant strains of Mycobacterium tuberculosis, two with Mycobacterium xenopi, one with Mycobacterium avium...
- Mycobacterial linear plasmids have an invertron-like structure related to other linear replicons in actinomycetesM Picardeau
Laboratoire de Référence des Mycobactéries, Institut Pasteur, Paris, France
Microbiology 144:1981-8. 1998The authors previously identified large plasmids in Mycobacterium xenopi, M. branderi and M. celatum which appeared to have a linear topology. This study has confirmed the presence of such linear plasmids in mycobacteria, including M...
- Mycobacteria other than tuberculosis with an emphasis on Mycobacterium xenopi in clinical specimens from AIDS patients at the University Hospital of Vienna from 1989 to 1996F Stauffer
Bundesstaatliche bakteriologisch serologische Untersuchungsanstalt Wien, Austria
Wien Klin Wochenschr 111:56-8. 1999..b>Mycobacterium xenopi was found to be the second most common nontuberculous mycobacterial species (92 specimens from 30 patients) ..
- Simple and rapid identification of different species of Mycobacteria by PCRL A Sechi
Sezione di Microbiologia Sperimentale e Clinica, Universita degli Studi di Sassari, Viale S Pietro 43 B, Sassari, 07100, Italy
Mol Cell Probes 13:141-6. 1999..and Mycobacterium bovis (both produced the same pattern), Mycobacterium avium, Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium chelonae, Mycobacterium peregrinum, Mycobacterium fortuitum, Mycobacterium gordonae and ..
- Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter studyE Tortoli
Laboratorio di Microbiologia e Virologia, Ospedale di Careggi, 50134 Florence, Italy
J Clin Microbiol 37:3578-82. 1999..tuberculosis complex, Mycobacterium xenopi, and the Mycobacterium avium complex, were analyzed separately and when combinations of a solid medium with ..
- Differentiation of Mycobacterium tuberculosis complex and nontuberculous mycobacterial liquid cultures by using peptide nucleic acid-fluorescence In situ hybridization probesF A Drobniewski
PHLS Mycobacterium Reference Unit, Department of Microbiology, Dulwich Public Health Laboratory, Guy s King s and St Thomas Medical School, Dulwich Hospital, London SE22 8QF, United Kingdom
J Clin Microbiol 38:444-7. 2000..5%) nontuberculous cultures were correctly identified (including one mixed culture). Five isolates yielded no reaction with either probe and were identified as Mycobacterium xenopi, Mycobacterium fortuitum, or Mycobacterium flavescens.
- Mycobacterium xenopi infection of the spine: a case report and literature reviewT Danesh Clough
Departments of Orthopaedics and Microbiology, Dunedin Hospital, Dunedin, New Zealand
Spine (Phila Pa 1976) 25:626-8. 2000STUDY DESIGN: A case report of Mycobacterium xenopi. OBJECTIVES: To present a case report of a vertebral osteomyelitis caused by M. xenopi and to review the world literature on the subject. SUMMARY OF BACKGROUND DATA: M...
- [Lung disease due to Mycobacterium xenopi excluding AIDS. Apropos of 8 cases]M Froidure
Service de Pneumologie et Reanimation Respiratoire, Hopital du Bocage, CHU de Dijon
Rev Mal Respir 17:481-7. 2000Between 1994 and early 1999, Mycobacterium xenopi was isolated in 11 HIV-negative patients seen at the Respiratory Disease Department of the Dijon University Hospital. Eight of these patients met the criteria of lung infection...
- Mycobacterium heckeshornense sp. nov., A new pathogenic slowly growing Mycobacterium sp. Causing cavitary lung disease in an immunocompetent patientA Roth
Institut für Mikrobiologie und Immunologie, 14109 Berlin, Institut fur Medizinische Mikrobiologie und Hygiene, Universitat Regensburg, 93053 Regensburg, Germany
J Clin Microbiol 38:4102-7. 2000A pathogenic scotochromogenic Mycobacterium xenopi-like organism was isolated from the lung of an immunocompetent young woman...
- Increasing incidence of Mycobacterium xenopi at Bellevue hospital: An emerging pathogen or a product of improved laboratory methods?V Donnabella
Bellevue Chest and Mycobacteriology Services, New York University School of Medicine, New York, NY 10016, USA
Chest 118:1365-70. 2000To investigate the dramatic rise in number of Mycobacterium xenopi isolates identified in our mycobacteriology laboratory, and to determine if this increase was due to emerging clinical pathology or to changes in culture technique.
- Efficacies of clarithromycin regimens against Mycobacterium xenopi in miceN Lounis
Laboratoire de Bacteriologie Hygiene, Faculté de Médecine Pitié Salpêtrière, Paris, France
Antimicrob Agents Chemother 45:3229-30. 2001Mice were infected intravenously with 3.5 x 10(7) CFU of Mycobacterium xenopi and treated with various clarithromycin-containing regimens or left untreated for 4 weeks...
- Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatmentC Bachmeyer
Departement de Medecine Interne, Hopital Laennec, F 60109 Creil, France
Thorax 56:978-9. 2001..We report a case of an HIV infected patient who developed granulomatous nodular and cavitatory lesions of the lungs due to Mycobacterium xenopi as a manifestation of the immune restoration syndrome.
- Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatmentC Bachmeyer
C Bachmeyer Département de Médecine Interne, Hopital Laennec, F 60109 Creil, France
Sex Transm Infect 78:60-1. 2002..We report a case of an HIV infected patient who developed granulomatous nodular and cavitatory lesions of the lungs due to Mycobacterium xenopi as a manifestation of the immune restoration syndrome.
- [Relative relatedness of 11 mycobacteria species by microplate hybridization methods considering delta Tm]Yutaka Fukasawa
Department of Microbiology and Bioinformatics, Gifu University Graduate School of Medicine, 40, Tsukasa machi, Gifu shi, Gifu 500 8705, Japan
Kekkaku 77:547-54. 2002Intra-species variance within Mycobacterium xenopi, Mycobacterium gordonae or Mycobacterium szulgai has been reported in identification employing chemotaxonomic characteristics, 16 S rRNA gene sequences or relative relatedness (relative ..
- Evaluation of a commercial line probe assay for identification of mycobacterium species from liquid and solid cultureW Mijs
Innogenetics NV, Industriepark 7, Box 4, 9052 Ghent, Belgium
Eur J Clin Microbiol Infect Dis 21:794-802. 2002..species and specifically identifies Mycobacterium tuberculosis complex, Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium gordonae, Mycobacterium avium complex, Mycobacterium avium, Mycobacterium intracellulare, ..
- Isolation of non-tuberculous mycobacteria from hospital cockroaches (Periplaneta americana)H H Pai
Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China
J Hosp Infect 53:224-8. 2003..In 12 cockroaches (P. americana): four Mycobacterium kansaii, three Mycobacterium xenopi, two Mycobacterium gordonae, one Mycobacterium hemophilium, one Mycobacterium fortuitum, and one ..
- In vitro activity of linezolid against slowly growing nontuberculous MycobacteriaBarbara A Brown-Elliott
Department of Microbiology, The University of Texas Health Center, Tyler, Texas, USA
Antimicrob Agents Chemother 47:1736-8. 2003..for all Mycobacterium marinum, Mycobacterium szulgai, Mycobacterium kansasii, Mycobacterium malmoense, and Mycobacterium xenopi isolates and for 90% of Mycobacterium gordonae and Mycobacterium triplex isolates were </=8 micro g/ml...
- Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosisFernando Alcaide
Servei de Microbiologia, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
J Clin Microbiol 41:2867-71. 2003..tuberculosis isolates and 61 (29.8%) nontuberculous mycobacterium isolates (30 Mycobacterium kansasii, 12 Mycobacterium xenopi, 9 Mycobacterium gordonae, 7 Mycobacterium avium complex, 2 Mycobacterium chelonae, and 1 Mycobacterium ..
- Pulmonary Mycobacterium xenopi infection in AIDS patients treated with HAART in HungaryJ Szlávik
Vth Department of Infectious Diseases, Saint László Hospital, Gyáli u 5 7, 1097 Budapest, Hungary
Eur J Clin Microbiol Infect Dis 22:701-3. 2003Reported here are three cases of pulmonary Mycobacterium xenopi infection that occurred in AIDS patients in Hungary shortly after starting highly active antiretroviral therapy...
- An unusual cause for a colonic stricture: a case of Mycobacterium xenopi mimicking malignancyJ R E Rees
Department of Surgery, Frenchay Hospital, Bristol, UK
Postgrad Med J 79:705-6. 2003..A case of mycobacterial disease mimicking malignancy is presented; this was due to a rare mycobacterial subtype and there was complete resolution of symptoms with antimycobacterial therapy...
- Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's diseaseC J Majoor
Department of Pulmonary Diseases, Jeroen Bosch Hospital, 5200 ME s Hertogenbosch, The Netherlands
Thorax 59:631-2. 2004..After 6 weeks Mycobacterium xenopi was cultured from his bronchial washings while all other cultures remained negative...
- A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infectionRoberto Manfredi
Department of Clinical and Experimental Medicine, Division of Infectious Diseases
HIV Clin Trials 5:206-15. 2004..is to investigate the epidemiology and in vitro antimicrobial susceptibility levels of 35 consecutive Mycobacterium xenopi strains responsible for confirmed disease at a University Hospital from 1993 to 2002 and to identify ..
- Concurrent granulomatous Pneumocystis carinii and Mycobacterium xenopi pneumonia: an unusual manifestation of HIV immune reconstitution diseaseF Chen
Department of Sexual Health, Whipps Goss University Hospital, London, UK
Thorax 59:997-9. 2004This report of concurrent granulomatous Pneumocystis carinii pneumonia (GPCP) and Mycobacterium xenopi pneumonia (MXIP) in a patient with advanced HIV disease 3-5 weeks after commencing antiretroviral therapy (ART) fits the syndrome of ..
- Spondylitis due to Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literatureAgnes Meybeck
Service des Maladies Infectieuses et Tropicales A, Hopital Bichat Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France
J Clin Microbiol 43:1465-6. 2005..We report a case of biopsy- and culture-proven Mycobacterium xenopi spondylitis in an AIDS patient and discuss approaches to diagnosis and therapy...
- Successful management of two heart transplant recipients with mycobacterial pulmonary infectionsTorsten Bossert
Department of Cardiac Surgery, University of Leipzig Heart Center, Leipzig, Germany
Ann Thorac Surg 80:719-21. 2005..and a 64-year-old man with nontuberculous mycobacterial infection with pulmonary infiltrates due to Mycobacterium xenopi. The time intervals from transplantation to diagnosis were 3 and 4 years, respectively...
- [Exclusive surgical treatment of Mycobacterium xenopi infection of a pulmonary cavity]E Leroy-Terquem
Service de Medecine Interne, Centre Hospitalier Intercommunal Meulan Les Mureaux, 1, rue du Fort, 78250 Meulan
Rev Pneumol Clin 61:261-3. 2005The diagnosis of pulmonary infection due to Mycobacterium xenopi was retained in a 48-year-old immunocompetent patient. The lesion was isolated in a peripheral region and was well limited. Exclusive surgical treatment was undertaken...
- Mycobacterium heckeshornense: an emerging pathogen responsible for a recurrent lung infectionF Jaureguy
Service de Bactériologie Virologie Hygiène, CHU Avicenne, 125 rue de Stalingrad, 93009 Bobigny Cedex, France
J Infect 54:e33-5. 2007..The pathogen, initially identified as Mycobacterium xenopi and considered as a contaminant, led to a delayed adapted antimicrobial treatment. Although M...
- Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteriaStephanie Petrella
Laboratoire de Recherche Moleculaire sur les Antibiotiques, LRMA INSERM U655, Universite Pierre et Marie Curie, F 75634 Paris Cedex 13, France
Antimicrob Agents Chemother 50:2853-6. 2006..was also investigated, revealing that the region involved in resistance to R207910 is conserved, except in Mycobacterium xenopi in which the highly conserved residue Ala63 is replaced by Met, a modification that may be associated with ..
- Utility of gas chromatography for rapid identification of mycobacterial species frequently encountered in clinical laboratoryAdriana Mosca
Section of Microbiology, Department of Clinical Medicine, Immunology and Infectious Diseases, University of Bari, Bari, Italy
J Microbiol Methods 68:392-5. 2007..Sixty-eight strains of Mycobacterium tuberculosis, Mycobacterium gordonae, Mycobacterium xenopi, Mycobacterium kansasii, Mycobacterium fortuitum, and Mycobacterium avium-intracellulare were clearly ..
- Interactions between Mycobacterium xenopi, amoeba and human cellsM Drancourt
Rickettsia Unit, Faculty of Medicine, Mediterranean University, Marseille, France
J Hosp Infect 65:138-42. 2007Outbreaks due to Mycobacterium xenopi have been linked with contaminated water. M. xenopi has been shown to interact with the biofilm formed in water distribution systems and to be hosted by free-living Acanthamoeba...
- Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanerceptNimrod Maimon
Division of Respirology, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
Thorax 62:739-40. 2007b>Mycobacterium xenopi is a water-related mycobacterium with low pathogenicity in humans. Little is known about the association between anti-tumour necrosis factor (TNF)alpha and non-tuberculous mycobacterial infections...
- Pulmonary disease caused by Mycobacterium xenopi: the first case in KoreaHye Yun Park
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon dong, Gangnam Gu, Seoul, Korea
Yonsei Med J 48:871-5. 2007b>Mycobacterium xenopi is a nontuberculous mycobacterium (NTM) that rarely causes pulmonary disease in Asia. Here we describe the first case of M. xenopi pulmonary disease in Korea...
- Catheter-related Leuconostoc bacteremia secondary to pulmonary Mycobacterium xenopi infectionMonika Huber
Pathologisch Bakteriologisches Institut, SMZ Otto Wagner Spital, Baumgartner Höhe, Vienna, Austria
Wien Klin Wochenschr 119:674-7. 2007..report a case of Leuconostoc bacteremia in a patient receiving antimycobacterial chemotherapy for pulmonary Mycobacterium xenopi infection...
- Spondylodiscitis caused by Mycobacterium xenopiR Sobottke
Department of Orthopaedic Surgery, University of Cologne, Cologne, Germany
Arch Orthop Trauma Surg 128:1047-53. 2008The infection with non-tuberculous mycobacterium correlates highly with immunodeficiency. Mycobacterium xenopi (M. xenopi) is most commonly isolated in the respiratory tract, as a cause of endogenous spondylodiscitis it occurs but rarely...
- Concomitant use of voriconazole and rifabutin in a patient with multiple infectionsJoshua N Schwiesow
Department of Pharmacy, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA
Pharmacotherapy 28:1076-80. 2008..We describe a 30-year-old woman with severe pulmonary disease associated with Mycobacterium xenopi and Aspergillus fumigatus, necessitating simultaneous antimycobacterial and antifungal therapy...
- Site-specific chemical modification of proteins with a prelabelled cysteine tag using the artificially split Mxe GyrA inteinThomas Kurpiers
Technische Universitat Dortmund, Fakultät Chemie Chemische Biologie, Otto Hahn Strasse 6, 44229 Dortmund, Germany
Chembiochem 9:2317-25. 2008..Here, we present the generation and biochemical characterisation of the artificially split Mycobacterium xenopi GyrA intein...
- Incidence of nontuberculous mycobacteria in four hot water systems using various types of disinfectionHelena Sebakova
Regional Public Health Authority of Moravian Silesian Region, Na Belidle 7, 70200 Ostrava, Czech Republic
Can J Microbiol 54:891-8. 2008..The detected NTM species were the pathogens Mycobacterium kansasii, Mycobacterium xenopi, and Mycobacterium fortuitum and the saprophyte Mycobacterium gordonae...
- Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east FranceC Andrejak
Pneumology Department, Teaching Hospital Amiens, Amiens, France
Thorax 64:291-6. 2009Owing to its low incidence, the management of Mycobacterium xenopi pulmonary infections is not clearly defined. A multicentre retrospective study was performed to describe the features of the disease and to evaluate its prognosis.
- [A possible case of pulmonary infection due to Mycobacterium heckenshornense]Akiko Hisamoto
Internal Medicine, Okayama Health Foundation Hospital
Nihon Kokyuki Gakkai Zasshi 46:1019-23. 2008..After 4 months, the strain of acid-fast bacilli was identified as Mycobacterium xenopi by DNA-DNA hybridization (DDH) method...
- Mycobacterium xenopi pulmonary disease - epidemiology and clinical features in non-immunocompromised patientsAnte Marusić
University Hospital for Lung Diseases Jordanovac, Department of Thoracic Radiology, Zagreb, Croatia
J Infect 58:108-12. 2009..Since, Mycobacterium xenopi is the most frequent NTM isolate in Croatia we studied its epidemiology and clinical relevance.
- Lung cavitation due to Mycobacterium xenopi in a renal transplant recipientL Martín-Penagos
Department of Nephrology, University Hospital Marqués de Valdecilla Santander, Santander Cantabria, Spain
Transpl Infect Dis 11:249-52. 2009b>Mycobacterium xenopi is an unusual pathogen and few such cases have been reported in the literature. We report the case of a patient with a sirolimus-based immunosuppressive regimen, who developed lung cavitation. M...
- Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patientsJakko van Ingen
Radboud University Nijmegen Medical Center, Department of Pulmonary Diseases, Nijmegen, The Netherlands
Int J Syst Evol Microbiol 59:845-9. 2009..These isolates were grouped because they revealed a unique 16S rRNA gene sequence and were related to Mycobacterium xenopi. None of the 17 patients met the American Thoracic Society diagnostic criteria for non-tuberculous ..
- Semisynthesis of membrane-attached prion proteinsNam Ky Chu
Technische Universitat Munchen, Department of Chemistry, Protein Chemistry Group, Garching, Germany
Methods Enzymol 462:177-93. 2009..In both cases, rPrP fused to a C-terminal extension comprising either the Mycobacterium xenopi GyrA mini-intein or the Synechocystis sp. DnaE N-terminal split intein is expressed in E. coli...
- [Radiographic findings of pulmonary nontuberculous mycobacteriosis other than Mycobacterium avium complex]Atsuyuki Kurashima
Fukujuji Hospital, Tokyo, Japan
Kekkaku 84:577-83. 2009..Mycobacterium fortuitum case shows nonspecific consolidations. Mycobacterium xenopi case shows solitary cavity in the upper lobe area...
- Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic reviewR G Varadi
Division of Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Int J Tuberc Lung Dis 13:1210-8. 2009The incidence of Mycobacterium xenopi infections is increasing worldwide. The characteristics and optimal management of patients with pulmonary M. xenopi infections have not been well established.
- Current treatment of atypical mycobacteriosisJaime Esteban
Department of Clinical Microbiology, Fundacion Jimenez Diaz, Av Reyes Catolicos 2, 28040 Madrid, Spain
Expert Opin Pharmacother 10:2787-99. 2009..This rising rate of infection is due mainly to the increase in the number of susceptible (and especially immunosuppressed) patients...
- In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The NetherlandsJakko van Ingen
Department of Pulmonary Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Int J Antimicrob Agents 35:169-73. 2010..to ciprofloxacin (44%) and amikacin (32%) was limited and was mostly restricted to Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium fortuitum and phylogenetically related species. Susceptibility to isoniazid (0...
- Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factorsClaire Andrejak
Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg and Aarhus, Denmark
Am J Respir Crit Care Med 181:514-21. 2010..Few population-based data are available regarding nontuberculous mycobacteria (NTM) pulmonary disease epidemiology and prognosis...
- Mycobacterium xenopi pulmonary infection resulting in self-limited immune reconstitution inflammatory syndrome in an HIV-1 infected patientSebastiano Leone
Infectious Diseases Division, A O R N San G Moscati, Avellino, Italy
New Microbiol 32:415-7. 2009..However, only a few cases of Mycobacterium xenopi associated IRIS have been described. This paper concerns a case of M...
- Lung disease caused by nontuberculous mycobacteriaGerardo Alvarez-Uria
Department of Infectious Diseases, Fundacion Vicente Ferrer, Rural Development Trust Hospital, Bathalapalli, Anantapur District, Andhra Pradesh, India
Curr Opin Pulm Med 16:251-6. 2010..In recent years, new information has appeared about other species and the pathogenesis of NTM...
- [Cutaneous and soft skin infections due to non-tuberculous mycobacteria]Fernando Alcaide
IDIBELL Hospital Universitario de Bellvitge, L Hospitalet de Llobregat, Barcelona, Espana
Enferm Infecc Microbiol Clin 28:46-50. 2010..marinum, Mycobacterium avium complex, Mycobacterium kansasii or Mycobacterium xenopi are world-wide distributed. In contrast, some others have a specific geographical distribution...
- Branched intermediate formation stimulates peptide bond cleavage in protein splicingSilvia Frutos
Laboratory of Synthetic Protein Chemistry, The Rockefeller University, New York, New York, USA
Nat Chem Biol 6:527-33. 2010..Our approach has been to prepare a branched intermediate (and analogs thereof) of the Mycobacterium xenopi DNA gyrase A (Mxe GyrA) intein using protein semisynthesis...
- Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model buildingTarek Aboul-Fadl
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P O Box 2457 Riyadh 14511, Saudi Arabia
Eur J Med Chem 45:4578-86. 2010..synthesized derivatives was investigated against four Mycobacterium strains: Mycobacterium intercellulari, Mycobacterium xenopi, Mycobacterium cheleneo and Mycobacterium smegmatis...
- The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, CanadaA Leber
Dept of Medicine, University Health Network, Mount Sinai Hospital, Toronto Western Hospital, Toronto, ON, M5T 2S8, Canada
Eur Respir J 37:1158-65. 2011..In multivariable analysis, Mycobacterium abscessus infection, i.v. therapy and Mycobacterium xenopi infection were all associated with increased monthly treatment costs...
- Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organismsPatent Number: JP2014195456-A; Date:2014-10-16
- POLYNUCLEOTIDES ENCODING BREX SYSTEM POLYPEPTIDES AND METHODS OF USING S AMEPatent Number: WO2015059690-A1; Date:2015-04-30
- DETECTION AND IDENTIFICATION OF MYCOBACTERIUM AND NOCARDIA USING SECAPatent Number: WO2005085478-A2; Date:2005-09-15
- Differential diagnosis for mycobacterial and pseudomonas species using species-specific upstream p34 gene region probesPatent Number: EP1233076-A2; Date:2002-08-21
- Method for controlling the microbiological quality of an aqueous medium and kit thereforPatent Number: WO0202811-A2; Date:2002-01-10
- Multi-gene expression constructs containing modified inteinsPatent Number: WO0159091-A2; Date:2001-08-16
- Kit for diagnosis of tubercle bacilliPatent Number: EP1076099-A2; Date:2001-02-14
- Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organismsPatent Number: WO0070086-A1; Date:2000-11-23
- diagnosis kit for Mycobacterium species identification and drug-resistance detection and manufaturing method thereofPatent Number: JP2003534810-A; Date:2003-11-25
- ENHANCED MULTIPLEX FISHPatent Number: KR1020130003002-A; Date:2013-01-08
- Oligonucleotide for detection of pathogenic microbial, diagnostickits and methods for detection of pathogenic microbial using theoligonucleotidePatent Number: KR1020040068313-A; Date:2004-08-28
- diagnosis kit for Mycobacterial gene to determine strain identityand drug-resistance and the manufacturing method thereofPatent Number: KR1020000029369-A; Date:2000-05-30
- Genes specific for species of Mycobacteria and a method for diagnosis, identification and characterization of M. tuberculosis andother MycobacteriaPatent Number: KR1019990046795-A; Date:1999-10-27
- IDENTIFICATION OF MYCOBACTERIAL SPECIES BY PCR-RFLP OF THE RNA POLYMERASE GENE(rpoB)Patent Number: KR1019970035501-A; Date:1997-07-28
- diagnosis kit for Mycobacterium species identification anddrug-resistance detection and manufaturing method thereofPatent Number: KR1020010072195-A; Date:2001-11-20
- FRAGMENTATION-BASED METHODS AND SYSTEMS FOR SEQUENCE VARIATION DETECTION AND DISCOVERYPatent Number: JP2006515987-A; Date:2006-06-15
- Nucleic acid probe-based assays for prokaryotic and eukaryotic organismsPatent Number: EP2365097-A1; Date:2011-09-14
- Nucleic acids and methods for characterizing mycobacteria to the genus-, group-, species-, and subspecies specific levelPatent Number: EP1254963-A1; Date:2002-11-06
- Molecular size markers for species identification of mycobacteriaePatent Number: WO2004029296-A2; Date:2004-04-08
- Enhanced Multiplex FISHPatent Number: JP2013520980-A; Date:2013-06-10
- Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organismsPatent Number: JP2011062202-A; Date:2011-03-31
- Nucleic Acid Beacons for Fluorescent in-situ Hybridisation and Chip TechnologyPatent Number: JP2010505429-A; Date:2010-02-25
- NUCLEOTIDE FRAGMENT OF MYCOBACTERIAL RIBOSOMAL RNA 23S, PROBES AND PRIMERS DERIVED THEREFROM, REAGENT AND METHOD FOR DETECTING SAID FRAGMENTPatent Number: WO9503412-A2; Date:1995-02-02
- Oligonucleotides derived from the SOD familyPatent Number: EP0592894-A1; Date:1994-04-20
- Screening And Use Of Agents Which Block Or Activate Intein Splicing Utilizing Natural Or Homologous ExteinsPatent Number: JP2004500050-A; Date:2004-01-08
- Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organismsPatent Number: JP2003526334-A; Date:2003-09-09
- Multi-gene expression constructs containing modified inteinsPatent Number: EP2159288-A2; Date:2010-03-03
- Multi-gene expression constructs containing modified inteinsPatent Number: EP2159287-A2; Date:2010-03-03
- ASSAYS FOR SHORT SEQUENCE VARIANTSPatent Number: JP2003518924-A; Date:2003-06-17
- Rpob gene fragments and a method for the diagnosis and identification of mycobacterium tubocolosis mycobacterial strainsPatent Number: JP2003512084-A; Date:2003-04-02
- Nucleic acid sequences and a method for genus-, group-, species- and sub-species-specific detection of mycobacteriaPatent Number: WO02090582-A2; Date:2002-11-14